MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma
出版年份 2018 全文链接
标题
MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-11-06
DOI
10.1186/s13046-018-0930-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma
- (2017) Yi Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism
- (2017) Li Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural Mesothelioma
- (2017) Hannah L. Moody et al. Molecular Therapy-Nucleic Acids
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance
- (2016) Bernadette M. Boac et al. GYNECOLOGIC ONCOLOGY
- Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma
- (2016) Chuan Tian et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma
- (2016) Gang Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma
- (2016) Fuqiang Yin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-induced drug resistance in gastric cancer
- (2015) Rashedeh Dehghanzadeh et al. BIOMEDICINE & PHARMACOTHERAPY
- An In Vivo Method to Identify microRNA Targets Not Predicted by Computation Algorithms: p21 Targeting by miR-92a in Cancer
- (2015) X. Su et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells
- (2013) Marzia Pennati et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9
- (2013) Zhuo Dong et al. CANCER LETTERS
- Enhancement of Synthetic Lethality via Combinations of ABT-888, a PARP Inhibitor, and Carboplatin In Vitro and In Vivo Using BRCA1 and BRCA2 Isogenic Models
- (2012) C. C. Clark et al. MOLECULAR CANCER THERAPEUTICS
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started